Equities

Kovo+Holdings Inc

KOVO:CVE

Kovo+Holdings Inc

Actions
  • Price (CAD)0.06
  • Today's Change0.00 / 0.00%
  • Shares traded5.00k
  • 1 Year change-33.33%
  • Beta0.6623
Data delayed at least 15 minutes, as of Nov 11 2024 16:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kovo+ Holdings Inc., formerly Kovo HealthTech Corporation, is a Canada-based technology company. The Company leads an innovative charge in artificial intelligence initiatives to drive impact and innovation across diverse industries. The Company enables healthcare providers digitally track and manage complex patient care registration, services, billing, and payments seamlessly. It also provides single trusted platform, intended to help healthcare stakeholders make informed decisions around operational and clinical initiatives. It offers cycle management and billing services for numerous hospitals and physician specialties, including mental health and all management systems and software. The Company also offers insurance claims billing services. From physical therapy to hearing specialists and more, their Web-based software allows organizations to access practice reports anytime.

  • Revenue in CAD (TTM)15.17m
  • Net income in CAD-7.66m
  • Incorporated2020
  • Employees--
  • Location
    Kovo+Holdings Inc1600 - 925 West Georgia StreetVANCOUVER V6C 3L2CanadaCAN
  • Websitehttps://www.kovo.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CardioComm Solutions Inc643.05k-141.08k1.93m16.00------3.00-0.0009-0.00090.0043-0.00351.621.283.63---35.58-56.56----92.0979.38-21.94-28.730.2911-9.29-----11.99-4.01-3,856.50---34.07--
ZoomMed Inc154.28k1.46m2.16m------1.4013.980.01070.01070.0011-0.001415.76--46.89--14,863.23----------943.16----------3,951.93--114.30------
EvokAI Creative Labs Inc0.00-13.65m2.28m-----------0.1467-0.14670.00-0.01050.00--0.3277---189.56-1,785.96-197.78-3,725.86-----------137.12---------3,520.74------
Binovi Technologies Corp-100.00bn-100.00bn2.31m0.00---------------0.0873-----------170.25---254.88--71.98---1,712.660.3215-------74.4213.94-79.12------
Lattice Biologics Ltd2.19m-1.34m4.24m--------1.93-0.0105-0.01050.01720.00111.013.838.70---61.69------28.53---61.08--0.00-1.020.00--12.60---46.52------
SQI Diagnostics Inc3.04m-19.13m6.18m55.00------2.03-0.0483-0.04830.0077-0.0350.2863.233.91---179.74-147.99---264.3310.9748.25-628.52-400.280.1193-3.0324.07--783.5352.95-75.46--42.57--
Kovo+Holdings Inc15.17m-7.66m7.99m--------0.5264-0.133-0.1330.2636-0.07811.17--48.85---58.91---242.80-------50.45-----1.231.51---5.04---1,773.60------
Evome Medical Technologies Inc57.98m-19.39m8.37m195.00------0.1444-0.2425-0.24250.6601-0.02791.073.216.91297,326.20-35.78---144.36--34.58---33.45--0.2596-1.941.14--------------
Data as of Nov 11 2024. Currency figures normalised to Kovo+Holdings Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.